NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/14/2026
Back to search
Official data from USPTO
RIGEL ONE CARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RIGEL ONE CARE
ST13
US500000087817100Class
35, 36, 44
Filing
87817100
Registration
6102551
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
01/15/2026
Trademark type
Word
Nice classes
35, 36, 44
Filing date
03/01/2018
Registration date
07/14/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/14/2026
Last transaction
01/15/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2018-06-00
First use in commerce
2018-06-00
Drawing code
4
Owner type
03
Owner location
South San Francisco, CA, US
Examiner
CAHILL, CLARE GALLAGHER
Current location
Historical data usage
Holders and representatives
Holders
Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc.
Representatives
Jamed J. Saul FAEGRE DRINKER BIDDLE & REATH LLP
Technical classification
Nice Classes
Class 35Class 36Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Providing a database for collecting and reporting information pertaining to medical treatmentinsuranceprescription drug dispensing and management for business purposes; Business administration of a patient support programwhich helps patientsin coordination with their healthcare provideraccessstartcomply with therapy as prescribedprovides co-pay assistanceassistance with insurance and healthcare providerscoverage and reimbursement informationgeneral education and supportinformation about productshealth topicsrelated resources; Providing business information and billing services in the field of healthcareproviding reimbursement informationdrug pricingpayment trackingco-payment data and other market intelligence to health care providersinsurers and consumers; Providing consumer product information relating to prescription drugs to distributorspharmacies and consumers; Distribution of product advertising materials for sales representatives of prescription drugs; Assisting patients in enrolling in pharmaceutical reimbursement programs of others; Providing a website featuring information for medical professionalspharmaciesinsurance companies and drug distributors regarding retail pharmacy business information about the administration and dosing of pharmaceuticals; Medical billing support servicesproviding an internet website portal featuring billing information to healthcare professionalspatients and patient caregivers relating to reimbursement for pharmaceutical preparationshealth care and prescription drugs
Class 36
Advisory services and consultancy regarding healthcare benefits and pharmacy benefits; providing information and guidance in connection with healthmedicalpharmacy insurance benefit plans; insurance consultation servicesassisting physician offices and patients to identify the scope of coverage offered by patient medical and pharmaceutical insurance; insurance consultation servicesassisting physician offices and patients to obtain prior authorization for medical and pharmaceutical insurance claims and the preparation and submission of related paperwork and assisting physician offices and patients to appeal denial of medical and pharmaceutical insurance claims and the preparation and submission of related paperwork; Financial informationproviding reimbursement informationdrug pricingpayment trackingco-payment information to health care providersinsurers and consumers; Financial administration of health reimbursement arrangementsproviding an internet website portal featuring financial information to healthcare professionalspatients and patient caregivers relating to reimbursement for pharmaceutical preparationshealth care and prescription drugs
Class 44
Medical information services; Medical informational servicesproviding information regarding prescription drugs for drug distributorsinsurance companiespharmacies and medical professionals; Providing a website featuring information for medical professionalspharmaciesinsurance companies and drug distributors regarding therapeutic properties of pharmaceuticalsthe treatment of diseases and medical conditionsmedical information about the administration and dosing of pharmaceuticals; Patient support services relating to treatment of medical disordersproviding information relating to therapeutic properties of pharmaceuticalsthe treatment of diseases and medical conditionsmedical information about the administration and dosing of pharmaceuticals; Providing a website featuring healthcare informationproviding resources in the field of pharmaceuticals for treatment of diseases and links to such resources; Medical information servicesproviding a website in the medicalpharmaceutical and health fields featuring information related to healthwellnesshealthcarepatient support servicespharmaceuticalspharmaceutical accessdrug safety and/or drug compatibility in relation to therapy and treatment of individualsadherence to pharmaceutical protocolsthe diagnosticprophylactic and therapeutic properties of pharmaceuticals; medical care consulting services in the fields of patient treatment and treatment protocols
Publications
History of USPTO decisions and trademark events.
44 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/14/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/12/2026
E815
TEAS SECTION 8 & 15 RECEIVED
10/08/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/14/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/03/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/03/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/03/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/03/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/03/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/25/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/25/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/25/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/25/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/25/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
07/14/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/12/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/11/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/19/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/19/2020
IUAF
USE AMENDMENT FILED
05/04/2020
EISU
TEAS STATEMENT OF USE RECEIVED
05/04/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/12/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/17/2019
PUBO
PUBLISHED FOR OPPOSITION
09/17/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/28/2019
ALIE
ASSIGNED TO LIE
08/09/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/31/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/30/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/29/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
07/29/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/13/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/29/2019
GNFR
FINAL REFUSAL E-MAILED
01/29/2019
CNFR
FINAL REFUSAL WRITTEN
01/29/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/22/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/20/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/20/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/20/2018
GNRT
NON-FINAL ACTION E-MAILED
06/20/2018
CNRT
NON-FINAL ACTION WRITTEN
06/20/2018
DOCK
ASSIGNED TO EXAMINER
06/12/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/08/2018
NWAP
NEW APPLICATION ENTERED
03/05/2018
Continuous trademark protection
Get notified about every new filing that threatens RIGEL ONE CARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.